Page 91 - AN-4-2

Advanced Neurology Alzheimer’s disease disclosure

7. Garrett MD. Social Dementia: The Role of Memory. USA: Disclosure of the diagnosis of dementia. Alzheimers Dement.
Kindle; 2021. 2007;3:404-410.
8. Crystal HA, Dickson D, Davies P, Masur D, Grober E, doi: 10.1016/j.jalz.2007.07.008
Lipton RB. The relative frequency of “dementia of unknown
etiology” increases with age and is nearly 50 percent in 18. Merckelbach H, Jelicic M, Jonker C. Planting a
nonagenarians. Arch Neurol. 2000;57:713-719. misdiagnosis of Alzheimer’s disease in a person’s mind. Acta
Neuropsychiatr. 2012;24:60-62.
doi: 10.1001/archneur.57.5.713
doi: 10.1111/j.1601-5215.2011.00586.x
9. Jack CR Jr., Andrews JS, Beach TG, et al. Revised
criteria for diagnosis and staging of Alzheimer’s disease: 19. Nelson ME, Jester DJ, Petkus AJ, Andel R. Cognitive
Alzheimer’s Association Workgroup. Alzheimers Dement. reserve, Alzheimer’s neuropathology, and risk of dementia:
2024;20:5143-5169. A systematic review and meta-analysis. Neuropsychol Rev.
2021;31:233-250.
doi: 10.1002/alz.13859
doi: 10.1007/s11065-021-09478-4
10. Snowdon DA, Nun Study. Healthy aging and dementia:
Findings from the Nun Study. Ann Intern Med. 20. Carapelle E, Mundi C, Cassano T, Avolio C. Interaction
2003;139:450-454. between cognitive reserve and biomarkers in Alzheimer
disease. Int J Mol Sci. 2020;21:6279.
doi: 10.7326/0003-481
11. Garrett MD. Multiple causes of dementia as engineered doi: 10.3390/ijms21176279
senescence. Eur J Med Health. 2020;2:227. 21. Soldan A, Pettigrew C, Albert M. Cognitive reserve from the
12. Öksüz N, Ghouri R, Taşdelen D, Uludüz D, Özge A. perspective of preclinical Alzheimer disease: 2020 update.
Mild cognitive impairment progression and Alzheimer’s Clin Geriatr Med. 2020;36:247-263.
disease risk: A comprehensive analysis of 3553 cases over doi: 10.1016/j.cger.2019.11.006
203 months. J Clin Med. 2024;13:518.
22. Robles MJ, Cucurella E, Informing of the diagnosis in
doi: 10.3390/jcm13020518 dementia. Spanish J Geriatr Gerontol. 2011;46:163-169.
13. Jack CR Jr., Bennett DA, Blennow K, et al. NIA-AA research doi: 10.1016/j.regg.2011.01.008
framework: Toward a biological definition of Alzheimer’s
disease Alzheimers Dement. 2018;14:535-562. 23. Beauchamp TL, Childress JF. Principles of Biomedical Ethics.
London: Oxford University Press; 1979.
doi: 10.1016/j.jalz.2018.02.018
24. McKhann GM, Albert MS, Grossman M, et al. Clinical and
14. Liss JL, Seleri Assunção S, Cummings J, et al. Practical pathological diagnosis of frontotemporal dementia: Report
recommendations for timely, accurate diagnosis of of the Work Group on Frontotemporal Dementia and Pick’s
symptomatic Alzheimer’s disease (MCI and dementia)
in primary care: A review and synthesis. J Intern Med. Disease. Arch Neurol. 2001;58:1803-1809.
2021;290:310-334. doi: 10.1001/archneur.58.11.1803
doi: 10.1111/joim.13244 25. Rascovsky K, Hodges JR, Knopman D, et al. Sensitivity of
15. Labos E, Cavagna M, Pagotto V, Schapira M. Seguimiento revised diagnostic criteria for the behavioural variant of
longitudinal de pacientes con queja cognitiva: Características frontotemporal dementia. Brain. 2011;134:2456-2477.
y perfiles de progresión. Vertex Rev Arg Psiquiatr. doi: 10.1093/brain/awr179
2021;32:45-54.
26. Cairns NJ, Bigio EH, Mackenzie IR, et al. Neuropathologic
16. Carapelle E, Mundi C, Cassano T, Avolio C. Interaction diagnostic and nosologic criteria for frontotemporal
between Cognitive Reserve and Biomarkers in Alzheimer lobar degeneration: Consensus of the consortium for
Disease. Int J Mol Sci. 2020;21:6279. frontotemporal lobar degeneration. Acta Neuropathol.
doi: 10.3390/ijms21176279 2007;114:5-22.
17. Fisk JD, Beattie BL, Donnelly M, Byszewski A, Molnar FJ. doi: 10.1007/s00401-007-0237-2

Volume 4 Issue 2 (2025) 85 doi: 10.36922/an.4393